住院医疗负担及影响全生命周期脑积水相关入院的因素
基于2019年美国KID和NIS数据库的横断面研究,分析儿童和成人脑积水分流相关入院的费用、人口学特征及影响因素。
要点
- 分流感染需翻修者中位费用71,300美元、中位住院25天,均高于初次置管(p<0.001)。
- 生命最初28天入院费用110,500美元、住院41天,分别为中位数22,700美元和5天的近5倍和8倍。
研究设计与样本
- 横断面研究,使用2019年医疗成本与利用项目儿童住院数据库(KID)和全国住院样本(NIS)的全国代表性加权出院数据。
- 通过ICD-10-CM/PCS编码筛选分流相关入院信息,入院年龄分为≤28天、29天至<1岁、1-18岁、19-64岁和≥65岁五组。
主要发现
- 每次入院中位费用22,700美元,中位住院时间5天;分流感染需翻修者中位费用71,300美元(p<0.001)、中位住院25天(p<0.001),均高于初次置管。
- 生命最初28天入院费用110,500美元 vs 中位数22,700美元,住院41天 vs 5天,分别为中位数的近5倍和8倍。
- ≥65岁人群占分流相关入院的28%;65.3%入院为非择期,非择期中位费用33,900美元 vs 择期15,100美元(p<0.001),住院9天 vs 2天(p<0.001)。
- 除19-64岁组女性占51.1%外,各年龄组分流相关入院以男性为主(54.7%-57.4%);33.1%使用私人保险,32.9%使用Medicare,27.7%使用Medicaid。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aims of this study were to quantify inpatient healthcare costs, describe patient demographics, and analyze variables influencing costs for pediatric and adult hydrocephalus shunt-related admissions in the US. METHODS: A cross-sectional study was performed using the 2019 Healthcare Cost and Utilization Project Kids' Inpatient Database (KID) and National Inpatient Sample (NIS), nationally representative weighted data sets of hospital discharges for pediatric and adult patients, respectively. International Classification of Diseases, 10th Revision, Clinical Modification and Procedure Coding System (ICD-10-CM/PCS) code filters for data extraction were queried for admission information. Age at admission was categorized into five groups (≤ 28 days, 29 days to < 1 year, 1-18 years, 19-64 years, and ≥ 65 years). RESULTS: In 2019, there were 36,898 shunt-related hospital admissions accounting for 495,138 hospital days and a total cost of more than $2.06 billion. Initial shunt placements accounted for 53.5% of all admissions and nearly 60% of the total cost. The median cost per admission was $22,700 and the median length of stay was 5 days. Admissions for shunt infection requiring revision had the highest median cost at $71,300 (p < 0.001) and the longest median length of stay at 25 days (p < 0.001) compared with initial shunt placements. By age, admissions that occurred in the first 28 days of life cost almost 5 times more than the median, $110,500 versus $22,700, respectively, and resulted in hospital stays that were 8 times longer than the median, 41 versus 5 days, respectively. Individuals aged ≥ 65 years accounted for 28% of the total shunt-related admissions. Almost two-thirds (65.3%) of shunt-related admissions were classified as nonelective. The median cost of nonelective procedures was double that of elective admissions, $33,900 versus $15,100, respectively (p < 0.001), and resulted in almost 5 times longer hospital stays, 9 versus 2 days, respectively (p < 0.001). Shunt-related admissions were predominantly male across all age groups (54.7%-57.4% male) except the 19- to 64-year age group. In the 19- to 64-year age group, females accounted for 51.1% of admissions. Insurance status was largely age dependent. Of all admissions, 33.1% used private insurance, 32.9% Medicare, and 27.7% Medicaid. CONCLUSIONS: This is the first study to quantify the patient demographics and cost of hydrocephalus shunt-related admissions across the entire age spectrum. Shunt-related admissions cost the US more than $2.06 billion dollars per year and represent only a fraction of the total cost of hydrocephalus care.
引用
- Koschnitzky JE, Yap E, Zhang Y, et al. Inpatient healthcare burden and variables influencing hydrocephalus-related admissions across the lifespan. J Neurosurg. 2022. PMID: 36681977. doi:10.3171/2022.10.JNS22330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。